Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies-Reference-Cited by-同舟云学术

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies

Published:2020-10-28 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Petricca Luca,Gigante Maria Rita,Paglionico Annamaria,Costanzi Stefano,Vischini Gisella,Di Mario Clara,Varriano Valentina,Tanti Giacomo,Tolusso Barbara,Alivernini Stefano,Grandaliano Giuseppe,Ferraccioli Gianfranco,Gremese Elisa

Publisher

Frontiers Media SA

Subject

General Medicine

Reference39 articles.

1. B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid;Berkani;Sci Rep.,2019

2. Association of bullous pemphigoid with systemic lupus erythematosus;Stoll;Arch Dermatol,1984

3. Systemic lupus erythematosus and coexisting bullous pemphigoid: immunofluorescent investigations;Clayton;J Am Acad Dermatol.,1982

4. Systemic lupus erythematosus and bullous pemphigoid with dramatic response to Dapsone;Maggio;Am J Case Rep.,2017

5. New insights into the immunopathogenesis of systemic lupus erythematosus;Tsokos;Nat Rev Rheumatol.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Biomarkers in Bullous Pemphigoid: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2024-07-29

2. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches;Clinical Reviews in Allergy & Immunology;2023-10-28

3. Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus;Life;2023-07-01

4. Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases;Frontiers in Medicine;2022-09-21

5. Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation;Journal of Molecular Modeling;2022-09-05